BioHealth News Archive
An Illustrated Subway Map of Human Anatomy
What comes to mind when you think about your body? Most people might imagine an intricate network of blood vessels or the complex neural…
Read More
Emergent BioSolutions Success Story – Maryland is Open for Business
With preparedness solutions that address emerging infectious diseases to chemical and biological threats, protecting and enhancing lives is at the heart of everything Emergent BioSolutions…
Read More
PathSensors Secures 5-year Department of Defense Contract for Building Protection | PathSensors
PathSensors, Inc., a rapidly growing, Baltimore-based biotechnology company focused on delivering pathogen detection solutions, announced today that it has been awarded a $7.2 million…
Read More
Adaptive Phage Therapeutics named in reporting citing Top 36 Startups Which Could Change the World – CB Insights Research
As stated by Josh Wolfe, co-founder and managing partner at Lux Capital, “the gap between ‘sci-fi’ — that which was once imagined — and…
Read More
Rexahn Pharmaceuticals names Doug Swirsky new CEO – Washington Business Journal
The new chief executive had joined the company in January — after selling his last biotech company for several million dollars. {iframe}https://www.bizjournals.com/washington/news/2018/11/21/not-business-as-usual-rockville-biopharma-s-new.html{/iframe}
Read More
Emergent BioSolutions and Valneva’s Zika vaccine turns up positive early-phase data – FiercePharma
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer…
Read More
THE ENTREPRENEURS REPORT: Private Company Financing Trends – Q3 2018
Market conditions for venture funding remained very strong in the third quarter of 2018. Deal size and pre-money valuations across all equity rounds decreased…
Read More
Living like a leader: A day with Children’s National Health System CEO Dr. Kurt Newman
Between clinical objectives, financial concerns, patient needs and complex payer dynamics, there seem to be too few hours in the day for healthcare executives…
Read More
GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia – Business Wire
GlycoMimetics, Inc. (NASDAQ: GLYC) announced today dosing of the first patient in the company’s Phase 3 clinical trial of uproleselan (GMI-1271) in relapsed/refractory AML.…
Read More
Emergent Bio’s Zika vaccine shows positive action in early-stage study – Seeking Alpha
Results from a Phase 1 clinical trial evaluating the safety and immunogenicity of Emergent BioSolutions' (NYSE:EBS) Zika vaccine, VLA1601, showed a favorable safety profile…
Read More
IBBR investigator to lead $3.9M NIH-funded project to develop next generation HIV-1 immunotherapy agents
IBBR researchers recently received $3.9 million from the National Institutes of Health (NIH) to develop a multi-specific, single agent antibody therapeutic against HIV-1 to…
Read More
Paragon Bioservices Named to Deloitte’s Technology Fast 500™
Paragon Bioservices, Inc. (Paragon), the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy and next-generation vaccines,…
Read More
What health IT needs to look like in 2019 to be successful – MedCity News
There’s no doubt that now is an exciting time for health IT. Many forward-thinking software companies are applying predictive models to create solutions that…
Read More
D.C.’s original site competition – The Washington Post
Amazon announced its HQ2 decision last Tuesday, splitting the decision between Crystal City and New York. But an earlier competition to site the nation’s…
Read More
Arena Inks $1.2 Billion Deal With United Therapeutics – Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) | Seeking Alpha
Arena Pharmaceuticals (ARNA) and United Therapeutics (UTHR) announced on Nov. 15 that the two companies have reached a deal on the pulmonary arterial hypertension…
Read More